Immune Design Corporation
1102 Columbia Street
Suite 104
Seattle
Washington
98104
United States
Website: http://www.immunedesign.com/
116 articles about Immune Design Corporation
-
Immune Design Corporation Announces Phase II Cancer Immunotherapy Trial Collaboration
8/12/2015
-
Immune Design Corporation And Merck & Co. To Collaborate On Combination Trials Of Two Immune Design Immunotherapies With Merck's KEYTRUDA For Non-Hodgkin's Lymphoma And Melanoma
8/10/2015
-
Immune Design Corporation To Report Second Quarter 2015 Financial Results
8/5/2015
-
Immune Design Corporation To Host June 2 Investor And Analyst Event In NYC
5/26/2015
-
Immune Design Corporation Reports First Quarter 2015 Financial Results
5/14/2015
-
Immune Design Corporation Announces Positive Data From Three Phase I Studies At The 2015 ASCO Annual Meeting
5/14/2015
-
Immune Design Corporation To Report First Quarter 2015 Financial Results And Provide ASCO Clinical Research Update
5/12/2015
-
Immune Design Corporation To Present At Upcoming Investment Conferences
5/11/2015
-
Immune Design Corporation Prices Public Offering Of Common Stock
4/16/2015
-
Immune Design Corporation Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Corporate Update
4/1/2015
-
Immune Design Corporation Announces Positive Topline Data From Three Phase 1 Clinical Trials Of Immuno-Oncology Agents
4/1/2015
-
Immune Design Corporation Announces Treatment Of Patients With CMB305 Investigational Immuno-Oncology Agent
3/26/2015
-
Immune Design Corporation Announces Upcoming Financial Results And Immuno-oncology Conference Presentation
3/23/2015
-
Immune Design Corporation Appoints Lewis W. Coleman To Board Of Directors
3/19/2015
-
Delaware Court Finds That THERAVECTYS Is Reasonably Likely To Succeed On The Merits Of Its Tortious Interference Claim Against Immune Design Corporation
3/11/2015
-
Immune Design Corporation To Present At Upcoming Investment Conferences
2/24/2015
-
Immune Design Corporation Announces First Patients Dosed In Phase 1 Clinical Trial Of G100 Investigational Immuno-Oncology Agent
2/11/2015
-
Immune Design Corporation To Present At The 2015 Leerink Global Healthcare Conference
2/5/2015
-
Immune Design Corporation To Present At The 33rd Annual J.P. Morgan Healthcare Conference
1/8/2015
-
Immune Design Corporation To Present At Jefferies and Co. 2014 Global Healthcare Conference
11/13/2014